Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2; the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:39:31.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added about the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:27:26.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays an updated site revision number.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content. Access to the study record is blocked as a result.
    Difference
    19%
    Check dated 2026-09-23T00:34:43.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page's revision metadata was updated to v3.7.0, replacing the previous v3.6.6 revision. This reflects an updated version of the page without changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T23:50:41.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page metadata. This update appears to reflect documentation or backend changes rather than modifications to the trial information presented.
    Difference
    0.1%
    Check dated 2026-09-01T19:51:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.